glimepiride and 2,4-thiazolidinedione

glimepiride has been researched along with 2,4-thiazolidinedione in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barnett, AH	1
Arondekar, B; Darkow, TE; Harley, C; Thayer, S	1
Dotta, F; Festa, A; Gallwitz, B; Guerci, B; Kiljański, J; Rosas-Guzmán, J; Schernthaner, G; Simó, R; Zhou, M	1

Reviews

1 review(s) available for glimepiride and 2,4-thiazolidinedione

Article	Year
Translating science into clinical practice: focus on vildagliptin in combination with metformin. Diabetes, obesity & metabolism, 2009, Volume: 11 Suppl 2 Topics: Adamantane; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Metformin; Nitriles; Pyrrolidines; Sulfonylurea Compounds; Thiazolidinediones; Vildagliptin	2009

Trials

1 trial(s) available for glimepiride and 2,4-thiazolidinedione

Article	Year
Treatment escalation options for patients with type 2 diabetes after failure of exenatide twice daily or glimepiride added to metformin: results from the prospective European Exenatide (EUREXA) study. Diabetes, obesity & metabolism, 2015, Volume: 17, Issue:7 Topics: Adult; Aged; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Drug Administration Schedule; Drug Therapy, Combination; Europe; Exenatide; Female; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Lipids; Male; Metformin; Middle Aged; Peptides; Prospective Studies; Sulfonylurea Compounds; Thiazolidinediones; Treatment Failure; Venoms	2015

Article

Year

Treatment escalation options for patients with type 2 diabetes after failure of exenatide twice daily or glimepiride added to metformin: results from the prospective European Exenatide (EUREXA) study.

Diabetes, obesity & metabolism, 2015, Volume: 17, Issue:7

Topics: Adult; Aged; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Drug Administration Schedule; Drug Therapy, Combination; Europe; Exenatide; Female; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Lipids; Male; Metformin; Middle Aged; Peptides; Prospective Studies; Sulfonylurea Compounds; Thiazolidinediones; Treatment Failure; Venoms

2015

Other Studies

1 other study(ies) available for glimepiride and 2,4-thiazolidinedione

Article	Year
Adherence to a fixed-dose combination of rosiglitazone/glimepiride in subjects switching from monotherapy or dual therapy with a thiazolidinedione and/or a sulfonylurea. The Annals of pharmacotherapy, 2010, Volume: 44, Issue:5 Topics: Cohort Studies; Databases, Factual; Diabetes Mellitus, Type 2; Drug Combinations; Drug Therapy, Combination; Drug Utilization; Humans; Hypoglycemic Agents; Patient Compliance; Retrospective Studies; Rosiglitazone; Sulfonylurea Compounds; Thiazolidinediones; Treatment Outcome	2010

Article

Year

Adherence to a fixed-dose combination of rosiglitazone/glimepiride in subjects switching from monotherapy or dual therapy with a thiazolidinedione and/or a sulfonylurea.

The Annals of pharmacotherapy, 2010, Volume: 44, Issue:5

Topics: Cohort Studies; Databases, Factual; Diabetes Mellitus, Type 2; Drug Combinations; Drug Therapy, Combination; Drug Utilization; Humans; Hypoglycemic Agents; Patient Compliance; Retrospective Studies; Rosiglitazone; Sulfonylurea Compounds; Thiazolidinediones; Treatment Outcome

2010